Advertisement
Screener

CRYO-CELL INTERNATIONAL, INC. (CCEL) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value

CRYO-CELL INTERNATIONAL, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value

CRYO-CELL INTERNATIONAL, INC. (CCEL) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value of $1.05 million for the 9-month period ending 2012-08-31, per its 10-Q filed 2012-10-15.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue · last filed 2012-10-15

  • 2012-08-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value 9 month $1.05M.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value 9 month
2012-08-31$1.05M
10-Q · filed 2012-10-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
MANGOCEUTICALS, INC. (MGRX)United States$0.010B-0.43
BioRestorative Therapies, Inc. (BRTX)United States$0.064B
Park Dental Partners, Inc. (PARK)United States$0.094B
VIEMED HEALTHCARE, INC. (VMD)United States$0.336B29.92
agilon health, inc. (AGL)United States$1.272B-7.76
Progyny, Inc. (PGNY)United States$1.994B28.37
Sotera Health Co (SHC)United States$5.271B30.96
DAVITA INC. (DVA)United States$11.147B16.80